Clinical study
Severe allopurinol toxicity: Description and guidelines for prevention in patients with renal insufficiency

https://doi.org/10.1016/0002-9343(84)90743-5Get rights and content

Abstract

A life-threatening toxicity syndrome consisting of an erythematous, desquamative skin rash, fever, hepatitis, eosinophilia, and worsening renal function in 78 patients receiving allopurinol is described. In a majority of cases, the development of this syndrome was associated with the use of standard (200 to 400 mg per day) doses of allopurinol in patients with renal insufficiency. In pharmacologic studies, it was demonstrated that the renal clearance of the major metabolite of allopurinol, oxipurinol, is directly proportional to the renal clearance of creatinine (oxipurinol clearance = 0.22 × creatinine clearance −2.87). An inverse linear relation was noted between the serum oxipurinol half-life and the renal creatinine clearance ([serum oxipurinol half-life in hours]−1 = 0.00034 × creatinine clearance in milliliters per minute + 0.0045). Long-term use of 300 mg per day of allopurinol was found to result in elevated steady-state serum oxipurinol concentrations in patients with renal insufficiency (serum oxipurinol concentration in micromoles per liter = −2.5 × creatinine clearance in milliliters per minute + 326). Avoidance of allopurinol or use of reduced doses in patients with renal insufficiency according to proposed guidelines should be adequate to inhibit uric acid production in most patients and may reduce the incidence of life-threatening allopurinol toxicity.

References (52)

  • TA Krenitsky et al.

    Inhibition of human purine nucleoside phosphorylase

    J Biol Chem

    (1968)
  • A Berken

    Allopurinol-induced suppressor T cell dysfunction: a hypothesis

    J Am Acad Dermatol

    (1981)
  • GB Elion et al.

    Renal clearance of oxipurinol, the chief metabolite of allopurinol

    Am J Med

    (1968)
  • KR Hande

    Allopurinol

  • MH Liang et al.

    Asymptomatic hyperuricemia: the case for conservative management

    Ann Intern Med

    (1978)
  • KR Hande et al.

    Allopurinol kinetics

    Clin Pharmacol Ther

    (1978)
  • JL Young et al.

    Severe allopurinol hypersensitivity: association with thiazides and prior renal compromise

    Arch Intern Med

    (1974)
  • DW Cockcroft et al.

    Prediction of creatinine clearance from serum creatinine

    Nephron

    (1976)
  • SW Lindsey et al.

    Allopurinol hypersensitivity syndrome: effects and treatment

    Va Med

    (1978)
  • TD Boyer et al.

    Allopurinol hypersensitivity vasculitis and liver damage

    West J Med

    (1977)
  • SK Chawla et al.

    Allopurinol hepatotoxicity

    Arthritis Rheum

    (1977)
  • LA Swank et al.

    Allopurinol induced granulomatous hepatitis with cholangitis and a sarcoid-like reaction

    Arch Intern Med

    (1978)
  • RC Butler et al.

    Massive hepatic necrosis in a patient receiving allopurinol

    JAMA

    (1977)
  • A Medline et al.

    Liver granulomas and allopurinol

    Br Med J

    (1978)
  • HL Chan et al.

    Allopurinol associated hypersensitivity reactions: cutaneous and renal manifestations

    Aust NZ J Med

    (1977)
  • TO Bennett et al.

    Ocular manifestations of toxic epidermal necrolysis associated with allopurinol use

    Arch Opthalmol

    (1977)
  • Cited by (638)

    • Hepatic Injury due to Drugs, Dietary and Herbal Supplements, Chemicals and Toxins

      2023, MacSween's Pathology of the Liver, Eighth Edition
    View all citing articles on Scopus

    This study was supported in part by grants from the Veterans Administration and Grant RO1-CA-26418 from the U.S. Public Health Service.

    1

    From the Departments of Medicine and Pharmacology, Vanderbilt University School of Medicine, and Veterans Administration Medical Center, Nashville, Tennessee.

    View full text